XML 237 R74.htm IDEA: XBRL DOCUMENT v3.22.1
Notes Payable (Narrative) (Details) - USD ($)
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Disclosure of reconciliation of liabilities arising from financing activities [line items]      
Cash receipts from sales of debt instruments $ 290,246    
Gain on settlement of financial liability $ 49,792 $ 680,164 $ (18,665)
Short-term notes      
Disclosure of reconciliation of liabilities arising from financing activities [line items]      
Notes payable, interest rate 10.00%    
Notes payable      
Disclosure of reconciliation of liabilities arising from financing activities [line items]      
Notes payable, interest rate 20.00%    
Settlement of notes payable $ 84,098    
Accrued interest settled 45,346    
Prismic Pharmaceuticals Inc. ("Prismic")      
Disclosure of reconciliation of liabilities arising from financing activities [line items]      
Settlement of notes payable 201,695    
Gain on settlement of financial liability $ 49,904